Oliver Wyman March 24, 2023
The push for more transparency and affordability in drug pricing continues to intensify. There are regulatory forces like the Inflation Reduction Act and market pressures ranging from benefit redesign to changes in formularies. The impact on patients can get lost in the mix, especially when it comes to specialty drugs.
“The specialty drug ecosystem is full of misdirected interactions and incentives that aren’t always aligned throughout the ecosystem,” Joe Cardosi, Founder, and CEO of Free Market Health, says in this video recorded at the 2022 Oliver Wyman Health Innovation Summit. “It’s a process that can be confusing...
Today's Sponsors
Today's Sponsor